AU2002244968A1 - Anti-osteopontin antibody and use thereof - Google Patents

Anti-osteopontin antibody and use thereof

Info

Publication number
AU2002244968A1
AU2002244968A1 AU2002244968A AU2002244968A AU2002244968A1 AU 2002244968 A1 AU2002244968 A1 AU 2002244968A1 AU 2002244968 A AU2002244968 A AU 2002244968A AU 2002244968 A AU2002244968 A AU 2002244968A AU 2002244968 A1 AU2002244968 A1 AU 2002244968A1
Authority
AU
Australia
Prior art keywords
osteopontin antibody
osteopontin
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002244968A
Other versions
AU2002244968B2 (en
Inventor
Shigeyuki Kon
Masaki Noda
Yukihiko Saeki
Toshimitsu Uede
Nobuchika Yamamoto
Yasuyuki Yokosaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Immuno Biological Laboratories Co Ltd
Original Assignee
Astellas Pharma Inc
Immuno Biological Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc, Immuno Biological Laboratories Co Ltd filed Critical Astellas Pharma Inc
Priority claimed from PCT/JP2002/003382 external-priority patent/WO2002081522A1/en
Publication of AU2002244968A1 publication Critical patent/AU2002244968A1/en
Assigned to ASTELLAS PHARMA INC., IMMUNO-BIOLOGICAL LABORATORIES CO., LTD. reassignment ASTELLAS PHARMA INC. Request for Assignment Assignors: FUJISAWA PHARMACEUTICAL CO., LTD, IMMUNO-BIOLOGICAL LABORATORIES CO., LTD.
Application granted granted Critical
Publication of AU2002244968B2 publication Critical patent/AU2002244968B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002244968A 2001-04-05 2002-04-04 Anti-osteopontin antibody and use thereof Ceased AU2002244968B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2001-107578 2001-04-05
JP2001107578 2001-04-05
JP2001-290700 2001-09-25
JP2001290700 2001-09-25
PCT/JP2002/003382 WO2002081522A1 (en) 2001-04-05 2002-04-04 Anti-osteopontin antibody and use thereof

Publications (2)

Publication Number Publication Date
AU2002244968A1 true AU2002244968A1 (en) 2003-04-10
AU2002244968B2 AU2002244968B2 (en) 2007-07-26

Family

ID=26613159

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002244968A Ceased AU2002244968B2 (en) 2001-04-05 2002-04-04 Anti-osteopontin antibody and use thereof

Country Status (20)

Country Link
US (2) US20040234524A1 (en)
EP (2) EP1754719A3 (en)
JP (1) JP4230776B2 (en)
KR (1) KR100881900B1 (en)
CN (1) CN100469793C (en)
AR (1) AR033121A1 (en)
AT (1) ATE412013T1 (en)
AU (1) AU2002244968B2 (en)
BR (1) BR0208809A (en)
CA (1) CA2443330A1 (en)
CZ (1) CZ20032697A3 (en)
DE (1) DE60229509D1 (en)
ES (1) ES2314040T3 (en)
HU (1) HUP0401561A2 (en)
MX (1) MXPA03009052A (en)
NO (1) NO20034405L (en)
NZ (1) NZ528483A (en)
PL (1) PL366469A1 (en)
RU (1) RU2299888C2 (en)
WO (1) WO2002081522A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004532633A (en) * 2001-05-09 2004-10-28 ビオ・ビジョン・アーゲー Method for detecting progressive chronic dementia disease, peptide and detection reagent suitable therefor
KR101008758B1 (en) 2001-09-18 2011-01-14 제넨테크, 인크. Compositions and Methods for the Diagnosis and Treatment of Tumor
EP1431310A4 (en) * 2001-09-25 2005-03-23 Immuno Biological Lab Co Ltd Recombinant anti-osteopontin antibody and use thereof
US7678889B2 (en) * 2002-08-06 2010-03-16 Diadexus, Inc. Compositions and methods relating to ovarian specific genes and proteins
WO2004103403A1 (en) * 2003-05-23 2004-12-02 Immuno-Biological Laboratories Co., Ltd. Immunocompetent cell activation inhibitor and use thereof
WO2005020785A2 (en) * 2003-07-15 2005-03-10 The Regents Of The University Of California Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis
AU2004324192A1 (en) * 2004-10-13 2006-04-27 Genentech, Inc. Method for treating tumors using anti-osteopontin antibodies
JP4871740B2 (en) 2005-01-13 2012-02-08 株式会社ジーンテクノサイエンス Anti-α9 integrin antibody and its use
CA2653661A1 (en) * 2006-05-31 2007-12-06 Astellas Pharma Inc. Humanized anti-human osteopontin antibody
DK2047863T3 (en) 2006-06-08 2013-09-16 Chugai Pharmaceutical Co Ltd MEDICINE FOR PREVENTION OR TREATMENT OF INFLAMMATORY DISEASES
WO2007149948A2 (en) * 2006-06-20 2007-12-27 The Gov. Of The Usa As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for diagnosis and treatment of tumors
KR101429783B1 (en) 2006-07-12 2014-08-18 가부시키가이샤 진 테크노 사이언스 Antihuman α9 integrin antibody and use of the same
EP2077325A4 (en) * 2006-09-11 2012-04-11 Immuno Biological Lab Co Ltd Monoclonal antibody and use thereof
DK2075258T3 (en) 2006-10-26 2012-09-17 Gene Techno Science Co Ltd Antibody to RGD in an amino acid sequence of an extracellular matrix protein as well as to its preparation and its use
CN101293916A (en) * 2007-04-24 2008-10-29 上海国健生物技术研究院 Monoclone antibody with combined function epiposition, specificity of osteopontin and uses thereof
CN101293924A (en) * 2007-04-24 2008-10-29 上海国健生物技术研究院 Monoclone antibody with combined function epiposition, specificity of osteopontin and in preparing antineoplastic diversion medicaments
KR100894265B1 (en) * 2007-06-05 2009-04-21 재단법인서울대학교산학협력재단 Injectable Bone Regeneration Gel containing Bone Formation Enhancing Peptide
EP2201383B1 (en) 2007-10-10 2014-01-15 Roche Diagnostics GmbH Means and methods for monitoring myocardial infarction and its treatment
EP2236604B1 (en) 2007-12-05 2016-07-06 Chugai Seiyaku Kabushiki Kaisha Anti-nr10 antibody and use thereof
JP2011509650A (en) 2008-01-11 2011-03-31 株式会社ジーンテクノサイエンス Humanized anti-α9 integrin antibody and use thereof
CN101918549B (en) 2008-01-11 2012-11-28 财团法人化学及血清疗法研究所 Improved humanized anti-human alpha9-integrin antibody
CA2721716C (en) 2008-04-24 2019-09-24 Gene Techno Science Co., Ltd. Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
EP2399937B1 (en) 2009-02-23 2016-04-27 Gene Techno Science Co., Ltd. Anti-human alpha9 integrin antibody and use thereof
EP2406285B1 (en) 2009-03-10 2016-03-09 Gene Techno Science Co., Ltd. Generation, expression and characterization of the humanized k33n monoclonal antibody
EP2431738A4 (en) * 2009-05-12 2013-05-22 Innopharmascreen Inc Method for screening osteopontin inhibitor and inhibitor prepared thereby
US8617829B2 (en) 2009-09-24 2013-12-31 Gene Techno Science Co., Ltd. Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof
WO2012117067A1 (en) 2011-03-01 2012-09-07 Novo Nordisk A/S Antagonistic dr3 ligands
GB2493540A (en) * 2011-08-10 2013-02-13 Follicum Ab Agents for stimulating hair growth in mammals
TW201623329A (en) 2014-06-30 2016-07-01 亞佛瑞司股份有限公司 Vaccines and monoclonal antibodies targeting truncated variants of osteopontin and uses thereof
CA2980992C (en) 2015-04-14 2024-01-23 Akihisa Kaneko Pharmaceutical composition for prevention and/or treatment of atopic dermatitis containing il-31 antagonist as active ingredient
WO2021030209A1 (en) * 2019-08-09 2021-02-18 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic antibodies against osteopontin
BR112022006590A2 (en) 2019-11-20 2022-06-28 Chugai Pharmaceutical Co Ltd PREPARATION CONTAINING ANTIBODIES

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US63241A (en) * 1867-03-26 Jacob green
US63247A (en) * 1867-03-26 hbtdeick
US171358A (en) * 1875-12-21 Improvement in machines for trimming and punching roofing-slates
US705842A (en) * 1901-10-25 1902-07-29 Daniel M Moroney Machine for assembling links in making chain belts.
US5459060A (en) * 1989-08-24 1995-10-17 Bioclonetics Incorporated Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1)
GB9122820D0 (en) * 1991-10-28 1991-12-11 Wellcome Found Stabilised antibodies
US6114143A (en) * 1993-03-11 2000-09-05 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Anti-HIV monoclonal antibody
EP0705842A2 (en) * 1994-10-06 1996-04-10 Hoechst Aktiengesellschaft Regulated genes by stimulation of chondrocytes with 1L-1beta
US6414219B1 (en) * 1998-06-30 2002-07-02 Rutgers, The State University Of New Jersey Osteopontin knock-out mouse and methods of use thereof
CA2370301A1 (en) * 1999-04-15 2000-10-26 Children's Medical Center Corporation Osteopontin-derived chemotactic and inhibitory agents and uses therefor
DE60131525T2 (en) * 2000-03-23 2008-09-25 Glaxo Group Ltd., Greenford PROCESS FOR SCREENING INHIBITORS FOR OSTEOPONTIN
EP1431310A4 (en) * 2001-09-25 2005-03-23 Immuno Biological Lab Co Ltd Recombinant anti-osteopontin antibody and use thereof

Similar Documents

Publication Publication Date Title
AU2002244968A1 (en) Anti-osteopontin antibody and use thereof
AU2002332290A1 (en) Recombinant anti-osteopontin antibody and use thereof
EP1375518A4 (en) Anti-osteopontin antibody and use thereof
HK1084127A1 (en) Recombinant anti-osteopontin antibody and use thereof
AU2002251913A1 (en) Hybrid antibodies and uses thereof
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU2002220843A1 (en) Humanised antibodies and uses thereof
AU2002340167A1 (en) Anti-hla-dr antibodies and the methods of using thereof
AU2001256325A1 (en) Human and humanized fap-alpha-specific antibodies
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2002365649A1 (en) Anti-dota antibody
AU2002365228A1 (en) Antigen panels and methods of using the same
AU2002343724A1 (en) Adhesive and use thereof
AU2003219093A1 (en) Anti-hpv-16 e7 antibodies and their use
EP1589033A4 (en) Antibody and use thereof
GB0122724D0 (en) Trx1 antibody and uses therefor
AU2002312373A1 (en) Structural and cytoskeleton-associated proteins
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2001261534A1 (en) The meca-79 antigen and related methods
AU2001253852A1 (en) Preprocalcitonin as tumor rejection antigen precursor and uses thereof
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2002251543A1 (en) Novel atisane compound and use thereof
AU2002338089A1 (en) Antibody and use thereof
EP1437367A4 (en) Antibody and use thereof
AU2002330299A1 (en) Antibody and use of the same